16 new COVID-19 deaths registered in Odisha; toll up at 875

Bhubaneswar:  Odisha registered 16 new deaths due to COVID-19 in the last 24 hours taking toll to 875.

“Regret to inform the demise of sixteen #COVID19 positive patients while under treatment in hospitals,” informed State Health & Family Welfare Department today.

The fresh deaths were reported from 7 districts. While Khordha district witnessed the highest of 6 deaths in the last 24 hours, 3 more succumbed to the deadly virus in Nayagarh district. The virus claimed two lives each in Balasore and Cuttack districts. One each died in Bargarh, Jagatsinghpur and Kalahandi districts.

Here’re details of 16 new deaths due to COVID-19 in Odisha:

1. A 60-year old female of Balasore district who was also suffering from Diabetes & Hypertension.

2. An 80-year old female of Balasore district who was also suffering from Diabetes & Hypertension.

3. A 47-year old male of Bargarh who was also suffering from Diabetes & Hypertension.

4. A 75-year old male of Bhubaneswar who was also suffering from Diabetes & Hypertension.

5. A 41-year old male of Bhubaneswar who was also suffering from Chronic Kidney Disease, Hypertension.

6. A 46-year old male of Bhubaneswar who was also suffering from Hypertension.

7. An 82-year old male of Bhubaneswar who was also suffering from Diabetes & Hypertension.

8. A 64-year old female of Cuttack district.

9. A 57-year old female of Cuttack district who was also suffering from Diabetes.

10. A 67-year old female of Jagatsinghpur district who was also suffering from Diabetes.

11. A 32-year old male of Kalahandi district.

12. An 84-year old female of Khordha district who was also suffering from Diabetes & Parkinsonism.

13. A 67-year old male of Khordha district who was also suffering from Diabetes & Hypertension.

14. A 76-year old male of Nayagarh district who was also suffering from Diabetes.

15. A 62-year old male of Nayagarh district.

16. A 52-year old female of Nayagarh district who was also suffering from Diabetes.

 

Also Read

Comments are closed.